Miroslav Tomka

Miroslav Tomka

Auto-generated profile, based on publicly available information

Miroslav Tomka

Comenius University, Faculty of Medicine, Institute of Medical Biology Genetics and Clinical Genetics Bratislava Slovakia

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2024 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
DKDaniela Klimova
Daniela Klimova
APAndrea Pastorakova
Andrea Pastorakova
MTMiroslav Tomka
Miroslav Tomka
CACestmir Altaner
Cestmir Altaner
VRVanda Repiska
Vanda Repiska

16 September 2026 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
ATAndrej Tóth
Andrej Tóth
SFSamuel Furka
Samuel Furka
JVJerguš Vengríni
Jerguš Vengríni
PNPavel Neogrády
Pavel Neogrády
ABAndrej Bandura
Andrej Bandura
DFDaniel Furka
Daniel Furka

29 April 2025 in Radiology Case Reports
Verified
Journal Article
Open access
MKMiroslav Kilian
Miroslav Kilian
RVRadovan Vanatka
Radovan Vanatka
RTRadka Tomasova
Radka Tomasova
IMIveta Meciarova
Iveta Meciarova
PHPeter Hlavcak
Peter Hlavcak
MTMiroslav Tomka
Miroslav Tomka
The successful treatment of any disease depends on early and correct diagnosis. A failure to establish an accurate diagnosis can lead to ineffective, often expensive treatment and risky progression of the disease with all the negative consequences, including incurability and death. The parosteal osteosarcoma is an illustrative example of how determining the correct diagnosis can be a challenging task. Parosteal osteosarcoma is a rare malignant bone tumor, mainly affected metaphysis of long bones. It arises from cortical surface of bone and it is usually slowly growing, low-grade, and well-differentiated tumor with good prognosis. Unfortunately, parosteal osteosarcoma is often misdiagnosed as a benign osteochondroma or myositis ossificans what leads to ineffective treatment, disease progression and systemic spreading with later treatment complications. In this article, we discuss a case of 48-years-old male with prolonged diagnosis of parosteal osteosarcoma, initially misdiagnosed as myositis ossificans. The diagnosis was revised and corrected based on results obtained by various approaches, including radiography, ultrasound-guided biopsy, histology, conventional cytology, and molecular biology. On this example, we demonstrate the importance of interdisciplinary collaboration between experts from different areas of health care.

1 January 2025 in Case Reports in Pediatrics
Verified
Journal Article
Open access
SLSilvia Lakatošová
Silvia Lakatošová
MMMichaela Miklošovičová
Michaela Miklošovičová
MKMichal Konecny
Michal Konecny
LWLenka Wachsmannová
Lenka Wachsmannová
GKGabriela Krasnanska
Gabriela Krasnanska
GRGabriela Repiska
Gabriela Repiska
Here, we present a case study of twin boys aged 2 and 7 years who both met the diagnostic criteria for autism spectrum disorders (ASDs) based on the standard diagnostic instruments ADOS‐2 and ADI‐R. The clinical indication for genetic diagnostics in the first boy was autism with high severity of symptoms, delayed speech development, and mild facial dysmorphia. The second boy’s indication was autism with moderate severity of symptoms, delayed speech development, mild facial features, slowed psychomotor development, and microcephaly. The microarray‐based analysis of chromosome aberrations revealed a heterozygous 977,456 bp deletion of region 10q26.3 in both boys. The region includes 28 genes, some of these genes are important in the development of the central nervous and urogenital systems, and heterozygous deletions in this region have been associated with mental retardation, growth and development disorders, and craniofacial anomalies. The whole exome sequencing confirmed the presence of this deletion in both boys and, at the same time, led to the identification of a pathogenic SNV variant in the TRIO gene in the boy with microcephaly and delayed psychomotor development, which may explain the different phenotype of both boys. However, the segregation analysis of these variants in the family revealed that the microdeletion was inherited from the asymptomatic father, and the c.2149C > T variant in the TRIO gene was inherited from the asymptomatic mother, making the diagnostic finding uncertain. This case highlights that when pathogenic or likely pathogenic variants are inherited from unaffected parents, the clinical phenotype may result from a combined burden of multiple rare variants and polygenic risk, underscoring the importance of a comprehensive genomic analysis in complex cases. Thus, we emphasize the importance of utilizing available methods, such as whole exome sequencing besides microarray‐based comparative genomic hybridization, in the genetic diagnosis of autism patients in Slovakia.